Optimizing urate-lowering therapy to achieve target serum urate levels may not harm, and may benefit ... absolute risk and an 11% lower relative risk of kidney function decline to an estimated ...

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.

A technology has been developed that can analyze tumor mutations in lung cancer patients to confirm drug resistance to ...

This week Novartis NVS upgraded its mid-term sales growth guidance. The European Commission approved Pfizer’s PFE hemophilia ...

Some 20% to 30% of gout patients also have CKD, the researchers said, which is not surprising since they share many risk ...

Without a reliable way to self-regulate blood glucose levels, patients are forced to live with a high-maintenance regimen of ...

Researchers recently collaborated on a novel, highly specific strategy to treat type 1 diabetes (T1D) using a tagged beta cell transplant in tandem with localized immune protection provided by ...

and novel agents (e.g. tirapazamine, EGFR inhibitors and other targeted agents) with radiotherapy will be examined. This article is part one of two articles. In the subsequent article, the general ...

GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...

After hours: November 22 at 5:30 PM EST Loading Chart for GFR ...

Discover how kidney function decline in ATTR-CM patients predicts higher mortality, highlighting its role as a critical marker in disease management and care optimisation.

Regenerative medicine holds the extraordinary promise that future patients in need of new cells, tissues or organs will no ...